Real-World Assessment of Efficacy and Safety Parameters for Dapagliflozin in Management of Type 2 Diabetes Mellitus: REWARD Study von Hassoun, Ahmed, Dhanwal, Denish Kumar, Nafach, Jalal, Ajaz, Yasmin, Khan, Asif Majid, Ben Nakhi, Abdullah, AlArouj, Monira, Hafidh, Khadija, AlNajjar, Majdi, Reyas, Ahmed, Qamar, Sana, Alsayed, Mohamed, Bdair, Ahmad

Volltext

DiabCare survey of diabetes management and complications in the Gulf countries von Omar, Muhamed, Khudada, Khaled, Safarini, Saher, Mehanna, Sherif, Nafach, Jalal

Volltext

808-P: Impact of Fasting on Adherence to Dosing Instructions and Efficacy of Oral Semaglutide during Ramadan in People with Type 2 Diabetes in Real-World Setting—O-SEMA-Fast Subana... von HASSANEIN, MOHAMED, ALKADHIM, IBRAHIM, ALY, HAZEM, BAJAWI, DALILA, CINAR, TARHAN, DHANWAL, DINESH, JABBAR, ABDUL, KHADER, SAID, KHUDADAH, KHALED, MUZAFFAR, TALAL, NGOME, MARY, NAFACH, JALAL, SHAGHOULI, AMNA

Volltext

Liraglutide as add‐on to sodium‐glucose co‐transporter‐2 inhibitors in patients with inadequately controlled type 2 diabetes: LIRA‐ADD2SGLT2i, a 26‐week, randomized, double‐blind,... von Blonde, Lawrence, Belousova, Lidia, Fainberg, Udi, Garcia‐Hernandez, Pedro A., Jain, Sunil M., Kaltoft, Margit S., Mosenzon, Ofri, Nafach, Jalal, Palle, Mads Sundby, Rea, Rosangela

Volltext

Earlier diagnosis of peripheral neuropathy in primary care: A call to action von Gad, Hoda, Kalra, Sanjay, Pinzon, Rizaldy, Gracia, Rey‐an Nino, Yotsombut, Kitiyot, Coetzee, Ankia, Nafach, Jalal, Lim, Lee‐Ling, Fletcher, Pablo E., Lim, Vivien, Malik, Rayaz A.

Volltext

Clinical Recommendations for the use of Neurotropic B vitamins (B1, B6, and B12) for the Management of Peripheral Neuropathy: Consensus from a Multidisciplinary Expert Panel von Pinzon, Rizaldy T, Schellack, Natalie, Matawaran, Bien J, Tsang, Man W, Deerochanawong, Chaicharn, Hiew, Fu L, Nafach, Jalal, Khadilkar, Satish

Volltext

Current Perspectives in Pre- and Diabetic Peripheral Neuropathy Diagnosis and Management: An Expert Statement for the Gulf Region von Beshyah, Salem A., Jayyousi, Amin, Al-Mamari, Ali Saif, Shaaban, Ashraf, Ozairi, Ebaa Al, Nafach, Jalal, Jallo, Mahir Khalil Ibrahim, Khader, Said, Evans, Marc

Volltext

OR22-1 Liraglutide as Add-on to SGLT2 Inhibitors in Patients with Inadequately Controlled Type 2 Diabetes (LIRA-ADD2SGLT2i): A 26-Week, Randomized, Double-Blind, Placebo-Controlled... von Blonde, Lawrence, Belousova, Lidia, Fainberg, Udi, Garcia-Hernandez, Pedro, Jain, Sunil, Kaltoft, Margit, Mosenzon, Ofri, Nafach, Jalal, Palle, Mads, Réa, Rosangela

Volltext

Efficacy and Safety of SGLT2 Inhibitors in Reducing Glycated Hemoglobin and Weight in Emirati Patients With Type 2 Diabetes von Bashier, Alaaeldin, Khalifa, Azza Abdulaziz, Rashid, Fauzia, Abdelgadir, Elamin Ibrahim, Al Qaysi, Amina Adil, Ali, Razan, Eltinay, Ahmed, Nafach, Jalal, Alsayyah, Fatima, Alawadi, Fatheya

Volltext